Delivery Order SPE2DB22D3004-SPE2DB25FPD34

Award Date 1/16/25
Potential Completion Date 1/17/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,968.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of EMERPHED 50 MG/10 ML SYRINGE 10ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 9, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and...
This is a federal contract award valued at $2,952.27 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide 4564287327 - EMERPHED 50 MG/10 ML SYRINGE 10ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and an Ultimate Completion Date of April 16, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EMERPHED 25 MG/5 ML SYRINGE 5ML. The contract has a Ceiling Value of $3,825.10 and a completion date of April 25, 2023. This award is a Firm Fixed Price contract, and there is no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of EMERPHED 50 MG/10 ML SYRINGE 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a firm fixed-price delivery order with a ceiling value of $1,972.92 and an ultimate completion date of July 12, 2024. Amerisourcebergen, a major pharmaceutical distribution company, is the prime contractor for this award. The contract is not set aside and was awarded on a...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,470.43 firm fixed-price delivery order is for the supply of EMERPHED 50 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of May 7, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,832.78, is for the delivery of EMERPHED 50 MG/10 ML VIAL 10ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of January 2, 2025. This award is not associated with a set-aside designation. Amerisourcebergen...
This is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), awarded to Amerisourcebergen Drug Corp. for the supply of 4565786556 - EMERPHED 50 MG/10 ML SYRINGE 10ML. The award has a ceiling value of $2,296.21 and a completion date of September 13, 2024. This contract is for the delivery of essential pharmaceutical products to support military treatment facilities and programs. Amerisourcebergen is a major supplier of medical...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,114.73 firm fixed-price delivery order is for the medication EMERPHED 50 MG/10 ML VIAL 10ML, with a performance period through May 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
This delivery order award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp for the supply of 4,565,295 units of the pharmaceutical product EMERPHED 50 MG/10 ML SYRINGE 10ML. The $1,640.15 firm-fixed price contract has a period of performance through July 31, 2024. Amerisourcebergen, a major pharmaceutical distributor, provides a wide range of medical commodities to federal agencies under various Indefinite Delivery Contracts, including a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of EMERPHED 50 MG/10 ML VIAL 10ML, a critical medical product, with a ceiling value of $1,014.24. The delivery order has a firm fixed-price pricing type and an ultimate completion date of July 24, 2024. Amerisourcebergen, through its extensive medical supply chain network, will provide this...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPD34
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of EMERPHED 50 MG/10 ML SYRINGE 10ML. The contract is a Delivery Order with a Firm Fixed Price, valued at $2,834.82, and has an ultimate completion date of January 17, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and the contract is associated with a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/1/25, 3:32 AM